GlassScriptPhysician profile
Michael S Bloom
NPI 1639128689
$9,729.06
in general payments reported to CMS, 2019-2025
33 companies · $2,408 in 2025
The $2,408 reported for 2025 was more than what 94% of Pediatric Ophthalmology and Strabismus Specialist providers received nationally (typical 2025 total: $118).
See the full distribution for Pediatric Ophthalmology and Strabismus Specialist
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $470 · 2021: $561 · 2022: $1,918 · 2023: $1,106 · 2024: $2,692 · 2025: $2,408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,819 · Education: $215 · Entertainment: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,818.71 |
| Education | $215.17 |
| Entertainment | $172.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,119.77 | 2020-2025 | Clareon, Hydrus Microstent, Lensx |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $853.78 | 2019-2021 | |
| Amgen INC. | $847.13 | 2024-2025 | Tepezza |
| Bausch & Lomb Americas INC. | $678.88 | 2022-2025 | Infuse, Biotrue One Day, Miebo |
| Sight Sciences, INC. | $514.15 | 2021-2023 | Omni Surgical System |
| Mallinckrodt Hospital Products INC. | $477.10 | 2024-2025 | Acthar |
| Biotissue Holdings INC. | $439.74 | 2022-2025 | |
| Abbvie INC. | $409.49 | 2022-2025 | Xen Glaucoma Treatment System, Lumigan, Alphagan P |
| Regeneron Healthcare Solutions, INC. | $397.45 | 2022-2025 | Eylea Hd |
| Johnson & Johnson Surgical Vision, INC. | $366.45 | 2024-2025 | Tecnis Simplicity, Tecnis Iol, Catalys System |
| Tarsus Pharmaceuticals, INC. | $282.75 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $248.93 | 2020-2025 | Idosetr |
| Allergan, INC. | $246.85 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $244.25 | 2022-2023 | Cequa |
| Ani Pharmaceuticals, INC. | $219.20 | 2024-2025 | Purified Cortrophin Gel |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $172.78 | 2023-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Microsurgical Technology, INC. | $152.49 | 2022 | |
| Rxsight INC | $151.59 | 2024-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Harrow Eye, LLC | $137.63 | 2024 | Iheezo, Triesence |
| Mallinckrodt Enterprises LLC | $123.06 | 2019 | |
| Aerie Pharmaceuticals, INC. | $108.26 | 2019 | |
| Horizon Therapeutics Plc | $97.10 | 2021-2023 | Tepezza |
| Apellis Pharmaceuticals, INC. | $95.59 | 2024-2025 | Syfovre |
| Sandoz INC. | $78.08 | 2024-2025 | Cimerli |
| Johnson & Johnson Vision Care, INC. | $51.43 | 2024 | |
| Dompe US, INC. | $47.86 | 2025 | Oxervate |
| Omeros Corporation | $33.93 | 2019-2021 | |
| Eyevance Pharmaceuticals LLC | $33.45 | 2022 | |
| Alimera Sciences, INC. | $25.31 | 2024 | Iluvien, Yutiq |
| Thea Pharma INC. | $24.51 | 2025 | Iyuzeh |
| Astellas Pharma US INC | $19.24 | 2024 | Izervay |
| Rayner Intraocular Lenses Limited | $17.31 | 2025 | Omidria |
| Oyster Point Pharma, INC. | $13.52 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bloom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.